triglyceride

head to head against clash football helmets fight combat
Pharma

Arrowhead data set up Redemplo for hypertriglyceridemia nod

Arrowhead has reported data from two phase 3 trials that could set the company up for Redemplo to gain approval to treat severe hypertriglyceridemia.
Kevin Dunleavy Jul 22, 2026 10:52am
The Supreme Court building

In a big win for generics drugmakers, SCOTUS sides with Hikma

Jun 4, 2026 3:11pm
Ionis headquarters

Ionis doubles its sales projection for Tryngolza in sHTG to $2B

Jan 13, 2026 3:45pm
home run

Ionis' Tryngolza win in sHTG sends shares soaring by 27%

Sep 2, 2025 11:30am
step up climb ladder sky hang on rung

Ionis chalks up phase 3 trial win as it works to grow Tryngolza

May 19, 2025 12:10pm
Three blocks displaying from left to right a person a handshake and another person

Ionis, Arrowhead sponsor new triglyceride education group

Mar 28, 2025 10:10am